Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Panel of Multivalent Nanobodies Broadly Neutralizing Omicron Subvariants and Recombinant.

Journal Of Medical Virology(2024)SCI 4区

Department of Critical Medicine | Southeast Univ | NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening | Shanxi Prov Hosp Tradit Chinese Med

Cited 1|Views22
Abstract
The emerging Omicron subvariants have a remarkable ability to spread and escape nearly all current monoclonal antibody (mAb) treatments. Although the virulence of SARS-CoV-2 has now diminished, it remains a significant threat to public health due to its high transmissibility and susceptibility to mutation. Therefore, it is urgent to develop broad-acting and potent therapeutics targeting current and emerging Omicron variants. Here, we identified a panel of Omicron BA.1 spike receptor-binding domain (RBD)-targeted nanobodies (Nbs) from a naive alpaca VHH library. This panel of Nbs exhibited high binding affinity to the spike RBD of wild-type, Alpha B.1.1.7, Beta B.1.351, Delta plus, Omicron BA.1, and BA.2. Through multivalent Nb construction, we obtained a subpanel of ultrapotent neutralizing Nbs against Omicron BA.1, BA.2, BF.7 and even emerging XBB.1.5, and XBB.1.16 pseudoviruses. Protein structure prediction and docking analysis showed that Nb trimer 2F2E5 targets two independent RBD epitopes, thus minimizing viral escape. Taken together, we obtained a panel of broad and ultrapotent neutralizing Nbs against Omicron BA.1, Omicron BA.2, BF.7, XBB.1.5, and XBB.1.16. These multivalent Nbs hold great promise for the treatment against SARS-CoV-2 infection and could possess a superwide neutralizing breadth against novel omicron mutants or recombinants.
More
Translated text
Key words
multivalent,neutralizing Nbs,Omicron,receptor-binding domain,SARS-CoV-2
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究发现了一组能够广泛中和Omicron亚变体的多价纳米抗体,具有对抗SARS-CoV-2感染及新型Omicron突变株或重组株的潜力。

方法】:通过从初免疫的羊驼VHH库中筛选,研究人员识别出一组针对Omicron BA.1尖峰蛋白受体结合域(RBD)的纳米抗体,并通过构建多价纳米抗体来实现超高中和活性。

实验】:研究人员利用一系列假病毒,包括Omicron BA.1,BA.2,BF.7以及新兴的XBB.1.5和XBB.1.16,验证了这些纳米抗体的中和效果。实验结果显示,纳米抗体三聚体2F2E5针对两个独立的RBD表位,减少了病毒逃逸的可能性。数据集名称未在摘要中明确提及。